This newest twist within the Lykos Therapeutics saga threatens A serious overhaul of the organization’s tactic and path, with Musk ally and billionaire Trader Antonio Gracias showing up to would like to choose the organization again toward its nonprofit drug improvement roots and a far more Doblinite philosophy.In many respects, the for-revenue c